Sitagliptin

(Januvia®)

Januvia®

Drug updated on 9/12/2023

Dosage FormTablet (oral; 100 mg, 50 mg, 25 mg)
Drug ClassDipeptidyl peptidase-4 (DPP-4) inhibitor
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • An adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.